© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Features

Donna Cryer Hep magazine liver disease
Leading the Global Liver Institute
Treatment News: The latest updates
Forums: Support and discussion

What’s the Skinny on Bone Health for People With HIV?

Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.

The United States of Opioids: The State of the Epidemic

Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.

The Annual Liver Meeting Roundup

The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.

Hepatitis C Treatments Are Safe and Effective for Seniors

The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
AbbVie's contract with Washington state includes outreach and testing to identify hepatitis C patients as well as the drugs to treat them.

Pharma Sells States On ‘Netflix Model’ To Wipe Out Hep C. But At What Price?

Kaiser Health News takes an in-depth look.
David Whiters

Dance to the Music

Health advocate David Whiters has mastered some smooth moves since overcoming addiction and hep C.

MUST read

Preventing Liver Cancer Among People With Hepatitis C
Cures With Benefits
How Sure Is a Cure?
The 2017 Hepatitis C Treatment Pipeline
EASL 2017 Roundup: Continued Progress in Fighting Liver Disease
Fighting Fatigue

When Will We See Drug Treatments for NASH Fibrosis?

Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.

The International AIDS Society Conference’s Most Vital Findings

A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.

Why Are Liver Disease Mortality Trends Shifting?

Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.

Hepatitis C Is a Risk Factor for Coronary Artery Disease

A meta-analysis has helped clear up conflicting previous evidence regarding this association.
Stella Armstrong

Happy Camper

Las Vegas resident Stella Armstrong cured her hep C and the joy-killing fatigue and pain that came with it.

Hot topics

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics
NASH: The Basics

Hep C Clearly Drives Liver Cancer, but What About Other Cancers?

A new systematic review and meta-analysis indicates that hepatitis C is most notably also associated with B-cell non–Hodgkin lymphoma.

International Liver Congress Roundup

A quick overview of our reporting on the 53rd International Liver Congress in Vienna
Adrian Mejia and his mother, Saira Diaz

Liver Illness Strikes Latino Children Like A ‘Silent Tsunami’

Recent research shows about 1 in 4 people in the United States have fatty liver disease. Among Latinos, the rate is significantly higher.

How Did U.S. Drug Prices Get To Be So High?

A look at the supply chain that results in very high costs for HIV and hepatitis C medications.

Hoosier Strong

Indianapolis native Matt Heskett beat both opioid addiction and hep C. Now he’s paying his good fortune forward with activism and education.
Advertisement
Treatment News
Newsfeed
Hep Stories
Ask Hep

Hot topics

Forums: Support and discussion
Blogs: The community speaks
Hep Stories: Get inspired
Magazine: Search the archives
#Coffee
A smiling Caucasian couple
#BabyBoomers